Researchers have revealed how a common bacterium, Enterococcus faecalis (E. faecalis), releases lactic acid to acidify its surroundings and suppress the immune-cell signal needed to start a proper ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...

If you've ever had a urinary tract infection (UTI), you know how miserable it can be: the burning, the itching, the constant ...

The European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of Emblaveo (aztreonam-avibactam), recommended for treating complicated intra-abdominal and urinary ...

A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers. The ...

Peptilogics' PLG0206 is a first-in-class anti-biofilm drug candidate being studied in patients with prosthetic joint infection (PJI), the first of multiple potential medical device-related infections ...

Bacterial endocarditis, or infective endocarditis, is a rare infection of the heart lining and valves. It is caused by a bacterial infection and results in flu-like symptoms. The condition may become ...

A new DNA sequencing technique that delivers faster and more accurate bacterial infection diagnoses could be implemented nationwide. The method, developed by the Medicines and Healthcare products ...

A new study from the CDC found that infection rates for a drug-resistant “nightmare bacteria” are on the rise, increasing nearly 70% between 2019 and 2023. The increase was primarily driven by the NDM ...